The incorporation of 5-fluorouracil into RNA affects the ribonucleolytic activity of the exosome subunit Rrp6

Molecular Cancer Research

Volumn 9, Issue 3, 2011, Pages 332-340

  Silverstein, Rebecca A ^a   De Valdivia, Ernesto González ^a,b   Visa, Neus ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; RIBONUCLEOPROTEIN; RNA; RRP6 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOTOXICITY; DROSOPHILA MELANOGASTER; EXOSOME; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SYNTHESIS;

ANIMALS; ANTIMETABOLITES; CELL CULTURE TECHNIQUES; CELL NUCLEUS; DROSOPHILA; DROSOPHILA PROTEINS; EXORIBONUCLEASES; EXOSOMES; FLUOROURACIL; GENE TRANSFER TECHNIQUES; HUMANS; NUCLEAR PROTEINS; RIBOSOMES; RNA;

EID: 79952837283     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0084     Document Type: Article

References (30)

1. Malet-Martino M, Martino R. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 2002;7:288-323. (Pubitemid 34919955)
2. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8. (Pubitemid 37328853)
3. Ladner RD. The role of dUTPase and uracil-DNA repair in cancer chemotherapy. Curr Protein Pept Sci 2001;2:361-70. (Pubitemid 33150476)
4. Doong SL, Dolnick BJ. 5-Fluorouracil substitution alters pre-mRNA splicing in vitro. J Biol Chem 1988;263:4467-73. (Pubitemid 18096631)
5. Patton JR. Ribonucleoprotein particle assembly and modification of U2 small nuclear RNA containing 5-fluorouridine. Biochemistry 1993;32:8939-44. (Pubitemid 23268819)
6. Ghoshal K, Jacob ST. Specific inhibition of preribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil. Cancer Res 1994;54:632-6. (Pubitemid 24068314)
7. Hoskins J, Butler JS. RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p. Genetics 2008;179:323-30.
8. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000;24:236-44. (Pubitemid 30132190)
9. Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004;116:121-37. (Pubitemid 38156189)
10. Schilders G, van Dijk E, Raijmakers R, Pruijn GJ. Cell and molecular biology of the exosome: how to make or break an RNA. Int Rev Cytol 2006;251:159-208. (Pubitemid 44291416)
11. Houseley J, LaCava J, Tollervey D. RNA-quality control by the exosome. Nat Rev Mol Cell Biol 2006;7:529-39. (Pubitemid 44036458)
12. Schmid M, Jensen TH. Quality control of mRNP in the nucleus. Chromosoma 2008;117:419-29.
13. Lebreton A, Séraphin B. Exosome-mediated quality control: substrate recruitment and molecular activity. Biochim Biophys Acta 2008;1779:558-65.
14. Schmid M, Jensen TH. The exosome: a multipurpose RNA-decay machine. Trends Biochem Sci 2008;33:501-10.
15. Lorentzen E, Basquin J, Conti E. Structural organization of the RNA-degrading exosome. Curr Opin Struct Biol 2008;18:709-13.
16. Andrulis ED, Werner J, Nazarian A, Erdjument-Bromage H, Tempst P, Lis JT. The RNA processing exosome is linked to elongating RNA polymerase II in Drosophila. Nature 2002;420:837-41. (Pubitemid 36019634)
17. Graham AC, Kiss DL, Andrulis ED. Core exosome-independent roles for Rrp6 in cell cycle progression. Mol Biol Cell 2009;20:2242-53.
18. Kammler S, Lykke-Andersen S, Jensen TH. The RNA exosome component hRrp6 is a target for 5-fluorouracil in human cells. Mol Cancer Res 2008;6:990-5.
19. Hessle V, Björk P, Sokolowski M, González de Valdivia E, Silverstein R, Artemenko K, et al. The exosome associates cotranscriptionally with the nascent pre-mRNP through interactions with heterogeneous nuclear ribonucleoproteins. Mol Biol Cell 2009;20:3459-70.
20. Graham AC, Kiss DL, Andrulis ED. Differential distribution of exosome subunits at the nuclear lamina and in cytoplasmic foci. Mol Biol Cell 2006;17:1399-409.
21. Synowsky SA, van Wijk M, Raijmakers R, Heck AJ. Comparative multiplexed mass spectrometric analyses of endogenously expressed yeast nuclear and cytoplasmic exosomes. J Mol Biol 2009;385:1300-13.
22. Callahan KP, Butler JS. TRAMP complex enhances RNA degradation by the nuclear exosome component Rrp6. J Biol Chem 2010; 285:3540-7.
23. Graham AC, Davis SM, Andrulis ED. Interdependent nucleocytoplasmic trafficking and interactions of Dis3 with Rrp6, the core exosome, and importin-alpha3. Traffic 2009;10:499-513.
24. Dziembowski A, Lorentzen E, Conti E, Séraphin B. A single subunit, Dis3, is essentially responsible for yeast exosome core activity. Nat Struct Mol Biol 2007;14:15-22. (Pubitemid 46067418)
25. Fang F, Hoskins J, Butler JS. 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Mol Cell Biol 2004;24:10766-76. (Pubitemid 39603133)
26. Chow CS, Lamichhane TN, Mahto SK. Expanding the nucleotide repertoire of the ribosome with post-transcriptional modifications. ACS Chem Biol 2007;2:610-9. (Pubitemid 350019778)
27. Goyle S, Maraveyas A. Chemotherapy for colorectal cancer. Dig Surg 2005;22:401-14.
28. Heide lberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957;179:663-6.
29. Greenhalgh DA, Parish JH. Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells. Cancer Chemother Pharmacol 1989;25:37-44. (Pubitemid 20000796)
30. Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 2006;310:211-50. (Pubitemid 47400292)